We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group (CME) to Report Q2 Earnings: What's in Store?
Read MoreHide Full Article
CME Group (CME - Free Report) is slated to report second-quarter 2020 results on Jul 29, before market opens. The company delivered negative earnings surprise of 1.3% in the last reported quarter.
Let’s see how things have shaped up for this announcement.
Factors to Consider
CME Group’s second-quarter results are likely to reflect its strong market position and varied derivative product lines. Non-transaction related opportunities, OTC offerings and its options business are likely to have contributed to top-line growth.
The company boasts a premier position with about 90% market share of the global futures trading and clearing services. However, given the impact of the pandemic, the Zacks Consensus Estimate for clearing and transaction fees is pegged at $953 million, indicating a decrease of 9.4% from the year-ago reported figure.
In second-quarter 2020, average daily volumes (ADV) decreased 16% year over year to 17.6 million contracts per day. Energy volume of 2.6 million contracts increased 4% from second-quarter 2019. Interest rate volume of 6.9 million contracts per day decreased 41% while Equity index volume of 5.6 million contracts per day increased 60%. However, Metals volume of 0.5 million contracts per day decreased 18%. Foreign exchange volumes dropped 17% to 0.7 million contracts per day. Agricultural volume of 1.3 million contracts per day decreased 29% from second-quarter 2019.
Higher compensation and benefits, technology expenses, professional fees and outside services, licensing and other fee agreements are likely to have increased expenses in the second quarter.
The Zacks Consensus Estimate for earnings per share is pegged at $1.62, indicating a decrease of nearly 8% from the year-ago quarter reported figure. The Zacks Consensus Estimate for revenues stands at $1.2 billion, indicating a downside of 6.1% from the year-ago quarter reported figure.
Our proven model does not conclusively predict an earnings beat for CME Group this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is not the case as you can see below.
Earnings ESP: CME Group has an Earnings ESP of 0.00%. This is because both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at $1.62. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Zacks Rank: CME Group currently carries a Zacks Rank of 4 (Sell).
Stocks to Consider
Some insurance stocks with the right combination of elements to come up with an earnings beat this time around are:
Cboe Global Markets (CBOE - Free Report) has an Earnings ESP of +0.48% and a Zacks Rank #3.
Allstate Corporation (ALL - Free Report) has an Earnings ESP of +11.10% and a Zacks Rank of 3.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys. Access Zacks Top 10 Stocks for 2020 today >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
CME Group (CME) to Report Q2 Earnings: What's in Store?
CME Group (CME - Free Report) is slated to report second-quarter 2020 results on Jul 29, before market opens. The company delivered negative earnings surprise of 1.3% in the last reported quarter.
Let’s see how things have shaped up for this announcement.
Factors to Consider
CME Group’s second-quarter results are likely to reflect its strong market position and varied derivative product lines. Non-transaction related opportunities, OTC offerings and its options business are likely to have contributed to top-line growth.
The company boasts a premier position with about 90% market share of the global futures trading and clearing services. However, given the impact of the pandemic, the Zacks Consensus Estimate for clearing and transaction fees is pegged at $953 million, indicating a decrease of 9.4% from the year-ago reported figure.
In second-quarter 2020, average daily volumes (ADV) decreased 16% year over year to 17.6 million contracts per day. Energy volume of 2.6 million contracts increased 4% from second-quarter 2019. Interest rate volume of 6.9 million contracts per day decreased 41% while Equity index volume of 5.6 million contracts per day increased 60%. However, Metals volume of 0.5 million contracts per day decreased 18%. Foreign exchange volumes dropped 17% to 0.7 million contracts per day. Agricultural volume of 1.3 million contracts per day decreased 29% from second-quarter 2019.
Higher compensation and benefits, technology expenses, professional fees and outside services, licensing and other fee agreements are likely to have increased expenses in the second quarter.
The Zacks Consensus Estimate for earnings per share is pegged at $1.62, indicating a decrease of nearly 8% from the year-ago quarter reported figure. The Zacks Consensus Estimate for revenues stands at $1.2 billion, indicating a downside of 6.1% from the year-ago quarter reported figure.
CME Group Inc. Price and EPS Surprise
CME Group Inc. price-eps-surprise | CME Group Inc. Quote
What the Zacks Model Says
Our proven model does not conclusively predict an earnings beat for CME Group this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is not the case as you can see below.
Earnings ESP: CME Group has an Earnings ESP of 0.00%. This is because both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at $1.62. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Zacks Rank: CME Group currently carries a Zacks Rank of 4 (Sell).
Stocks to Consider
Some insurance stocks with the right combination of elements to come up with an earnings beat this time around are:
American Financial Group (AFG - Free Report) has an Earnings ESP of +21.45% and a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Cboe Global Markets (CBOE - Free Report) has an Earnings ESP of +0.48% and a Zacks Rank #3.
Allstate Corporation (ALL - Free Report) has an Earnings ESP of +11.10% and a Zacks Rank of 3.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>